sc 58125 has been researched along with transforming growth factor alpha in 1 studies
| Studies (sc 58125) | Trials (sc 58125) | Recent Studies (post-2010) (sc 58125) | Studies (transforming growth factor alpha) | Trials (transforming growth factor alpha) | Recent Studies (post-2010) (transforming growth factor alpha) |
|---|---|---|---|---|---|
| 93 | 0 | 15 | 4,301 | 44 | 623 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chinery, R; Coffey, RJ; Damstrup, L; Daniel, VC; Dempsey, PJ; DuBois, RN; Graves-Deal, R; Hawkey, CJ; Jetton, TL; Kirkland, SC; Morrow, JD | 1 |
1 other study(ies) available for sc 58125 and transforming growth factor alpha
| Article | Year |
|---|---|
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.
Topics: Amphiregulin; Cell Compartmentation; Cell Nucleus; Cell Polarity; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; EGF Family of Proteins; ErbB Receptors; Glycoproteins; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Isoenzymes; Membrane Proteins; Mitosis; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; RNA, Neoplasm; Sulfonamides; Sulindac; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1997 |